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Li et al., http ://dx .doi .org /10 .1083 /jcb .201602090 Figure S1 . Loss of scav-3 affects lysosome morphology and dynamics. (A-K) Confocal fluorescent images of wild-type (WT; A-C), scav-3(qx193) (D-F), and lmp-2(tm6600) lmp-1(nr2045) (G-I) adults or larvae (J and K) expressing LAAT-1::GFP in gonadal sheath cells, body wall muscles, intestine, and hypodermal cells. Arrowheads, globular lysosomes; arrows, tubular lysosomes; blue arrows, abnormally thick tubules in scav-3(qx193) . (L and M) Timelapse images of lysosomes in the hypodermis of wild-type (L) and scav-3(qx193) (M) larvae expressing LAAT-1::GFP. Arrows indicate lysosomal changes that were followed and arrowheads designate static lysosomes in scav-3(qx193) . (N) Time-lapse images of lysosomes in the hypodermis of wild type and lmp-2 lmp-1 expressing NUC-1::mCherry, with time point 0 s in red and 20 s in green. The overlay (merge) shows lysosome movement over time. Arrows indicate dynamic changes of lysosomes in wild type and lmp-2 lmp-1. Pearson's correlation coefficient was determined and is shown in the right panel. Data are shown as mean ± SD. At least 10 movies were analyzed in each strain. Data were compared with the unpaired t test. N.S., no significance.
(O-R″) Confocal fluorescent images of the hypodermis in different scav-3 mutant alleles expressing GBA-3::mCherry and LAAT-1::GFP. GBA-3::mCherry colocalizes with LAAT-1::GFP (arrows) in all scav-3 mutant alleles. Bars, 10 µm. (3N-2) , or SCAV-3(6N). Expression of wild-type (WT) SCAV-3 but not SCAV-3(3N-2) or SCAV-3(6N) rescued the damaged lysosome phenotype in scav-3(qx193). The percentage of rescue activity is quantified in O. At least 15 worms were scored in each strain. The distribution of the rescue activity is shown, and black lines represent the mean rescue activity (O). One-way ANO VA with Tukey's posttest was performed to compare all the other datasets with the wild-type SCAV-3. **, P < 0.0001. (M and N) Wild-type and mutant versions of SCAV-3 ::GFP (M) or LMP-1::BFP (N) that lack multiple glycosylation sites were expressed in scav-3(qx193), then worm extracts were analyzed by Western blot using anti-SCAV-3 or anti-LMP-1 antibodies. PNGase F treatment was performed to remove the glycosylation of SCAV-3::GFP and LMP-1::BFP. The black and red asterisks indicate SCAV-3 or LMP-1 with or without the GFP or BFP fusion. The red arrowheads indicate the glycosylated proteins that are sensitive to PNGase treatment and may be affected in SCAV-3(3N-1) and LMP-1(3N). The protein levels of SCAV-3(3N-2)::GFP and SCAV-3(6N)::GFP were very low, likely because of the instability of the deglycosylated protein. The apparent molecular weight of LMP-1 (N, black asterisk) is bigger than its theoretical molecular weight and is not altered by PNGase treatment. (P) CPL-1 processing in lysosomes prepared from worms at day 1 of adulthood. The processing of CPL-1 is revealed by Western blot using anti-CPL-1 antibodies (full length, 38 kD; processed active form, 27 kD) and was used to determine the enrichment of lysosomes in different fractions (B1-4) separated by a density gradient as described in Materials and methods. Bars, 10 µm. In Q and U, the number of sfGFP::Gal3-positive membrane-like structures was quantified in hypodermal cell 7 (hyp7) of the indicated strains. At least 15 animals were scored in each strain, and data are shown as mean ± SD. One-way ANO VA with Tukey's posttest was performed to compare the datasets that are linked by lines. **, P < 0.0001; N.S., no significance. Bars, 10 µm.
